Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-09

Clinical Trial Update: Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)

View source ↗

Summary

This document reports a completed compassionate-use clinical trial of ceftriaxone in patients with amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid | Status: COMPLETED